title: Should nonsteroidal anti-inflammatory drugs (NSAIDs) be prescribed to the older adult?
abstract: The prevalence of chronic pain increases with age, exceeding 50% in individuals aged ≥65 years. Nonsteroidal anti-inflammatory drugs (NSAIDs) are a mainstay of chronic pain management but carry significant dose-related risks of cardiovascular, renal, haematological and other systemic adverse events (AEs). Older patients have an increased risk of these AEs and are more likely to take multiple medications that can potentially interact with NSAIDs. In particular, older patients are more likely to have cardiovascular disease and a natural age-related decline in renal function, increasing the risks of cardiovascular, haematological and renal AEs. Given these risks, recent guidelines for the management of chronic pain in the elderly recommend using NSAIDs rarely and only in carefully selected patients. NSAIDs currently available in the US fall into three categories: nonselective NSAIDs that act via inhibition of cyclo-oxygenase (COX)-1 and COX-2; celecoxib, a selective inhibitor of COX-2; and topical NSAIDs that inhibit both COX-1 and COX-2 but result in much less systemic NSAID exposure than oral formulations. Topical NSAIDs have demonstrated efficacy similar to oral NSAIDs, with an incidence of AEs similar to placebo; however, these agents are an option only in patients with localized pain in superficial joints. Safe pain management in older patients therefore requires cautious choice of selective and nonselective oral NSAIDs, topical NSAIDs or non-NSAID analgesics. This article discusses the risks and benefits of NSAID therapy, reviews its mechanism of action as the source of adverse effects and provides recommendations for maximizing NSAID safety, particularly in older patients. Articles cited in this review were identified via a search of PubMed (January 2005 to November 2009) and a manual search of reference lists from the articles identified in that search. Priority was given to articles discussing NSAID use in older populations, clinical trials of high quality, reports on NSAID safety and AEs, and treatment guidelines.
authors.affiliation: Department of Anesthesiology, Rush University Medical Center, Chicago, Illinois, USA.
authors.forename: Robert L
authors.initials: RL
authors.lastname: Barkin
authors.forename: Mihail
authors.initials: M
authors.lastname: Beckerman
authors.forename: Steven L
authors.initials: SL
authors.lastname: Blum
authors.forename: Frank M
authors.initials: FM
authors.lastname: Clark
authors.forename: Eun-Kyu
authors.initials: EK
authors.lastname: Koh
authors.forename: Dickson S
authors.initials: DS
authors.lastname: Wu
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D002319:Cardiovascular System / Q000187:drug effects; D005260:Female; D006801:Humans; D008099:Liver / Q000187:drug effects; D008297:Male; D010146:Pain / Q000188:drug therapy; D012307:Risk Factors
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal